Founded in 2001, RA Capital Management is a hedge fund manager based in Boston, Massachusetts. The firm focuses on evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices and diagnostics sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
SeLux | 28-Feb-2022 | Later Stage VC | 000.00 | Other Healthcare Technology Systems | Generating Revenue | 00000 0000000000 00.0 |
0000000 | 23-Feb-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
0000000 | 23-Feb-2022 | 00000 00000 | 00000 | Clinics/Outpatient Services | Generating Revenue | |
00000000 | 17-Feb-2022 | 00000 00000 | 00000 | Biotechnology | Generating Revenue | |
0000000 0000000000 | 16-Feb-2022 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 1 | |
00000 00000000 000 | 16-Feb-2022 | 00000 00000 | 00000 | Discovery Tools (Healthcare) | Clinical Trials - Phase 1 | |
000000 0000000 | 10-Feb-2022 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 00000 00000 00.0 |
0000000 0000000000 | 10-Feb-2022 | 00000 00000 | 0000 | Biotechnology | Pre-Clinical Trials | 00000 0000000 00.0 |
Ventus Therapeutics | 09-Feb-2022 | Later Stage VC | 00000 | Drug Discovery | Generating Revenue | 000000 0000000 00 |
Metagenomi | 21-Jan-2022 | Later Stage VC | 00000 | Drug Discovery | Generating Revenue | 000000 00000 00.0 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Ivantis | 10-Jan-2022 | Merger/Acquisition | |
00 0000000 | 05-Nov-2021 | 000 | 00000 |
0000000 | 01-Nov-2021 | 000 | 00000 |
00000 000000000000 | 22-Oct-2021 | 000 | 00000 |
00000 00000000 | 08-Oct-2021 | 000 | 00000 |
0000 000000000 | 15-Sep-2021 | 000 | 00000 |
0000 00000000000 | 15-Sep-2021 | 000 | 00000 |
00000 000000000000 | 10-Aug-2021 | 000 | 0000 |
Adagio Therapeutics | 06-Aug-2021 | IPO | 00000 |
Vividion Therapeutics | 01-Aug-2021 | Merger/Acquisition | 00.00 |
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialName | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Kai Wu | Chief Financial Officer | Boston, MA | |||
Michael Saulnier | Chief Financial Officer | Boston, MA | |||
Andrew Levin Ph.D | Managing Director | 00 | 0 | 0 | Boston, MA |
Mario Barro Ph.D | Managing Director of Innovation | 0 | 0 | 0 | Boston, MA |
Pieter Boelhouwer JD | Managing Director, Strategy and Operations | 0 | Boston, MA |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Janus Henderson Investors | 31 | 0 | 0 | ||
Logos Capital | 00 | 0 | 0 | ||
Cormorant Asset Management | 00 | 0 | 0 | ||
OrbiMed | 00 | 0 | 00 | ||
Perceptive Advisors | 00 | 0 | 00 |